{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:28:33Z","timestamp":1787941713330,"version":"build-2784847793"},"reference-count":20,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Susceptibility to piperacillin was similar to that to piperacillin-tazobactam (&lt;1% difference) for 6,938 isolates of\n            <jats:italic>Enterobacter aerogenes<\/jats:italic>\n            and 13,954 isolates of\n            <jats:italic>Enterobacter cloacae<\/jats:italic>\n            tested using a Vitek system; for the same species, in contrast, susceptibility rates to piperacillin-tazobactam were 5.9 to 13.9% higher than to piperacillin using disk diffusion, MicroScan, and Vitek 2 testing. Unprecedented phenotypes (piperacillin susceptible and piperacillin-tazobactam intermediate; piperacillin intermediate and piperacillin-tazobactam resistant; piperacillin susceptible and piperacillin-tazobactam resistant) accounted for 6.1% of the results for\n            <jats:italic>E. aerogenes<\/jats:italic>\n            isolates and 6.0% of the results for\n            <jats:italic>E. cloacae<\/jats:italic>\n            isolates tested with the Vitek system.\n          <\/jats:p>","DOI":"10.1128\/jcm.41.7.3339-3343.2003","type":"journal-article","created":{"date-parts":[[2003,7,3]],"date-time":"2003-07-03T19:05:48Z","timestamp":1057259148000},"page":"3339-3343","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Four Antimicrobial Susceptibility Testing Methods To Determine the In Vitro Activities of Piperacillin and Piperacillin-Tazobactam against Clinical Isolates of\n            <i>Enterobacteriaceae<\/i>\n            and\n            <i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1128","volume":"41","author":[{"given":"James A.","family":"Karlowsky","sequence":"first","affiliation":[{"name":"Focus Technologies, Herndon, Virginia 20171"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellany K.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Focus Technologies, Herndon, Virginia 20171"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde","family":"Thornsberry","sequence":"additional","affiliation":[{"name":"Focus Technologies, Herndon, Virginia 20171"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Dowzicky","sequence":"additional","affiliation":[{"name":"Wyeth Pharmaceuticals, Saint Davids, Pennsylvania 19087"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Jones","sequence":"additional","affiliation":[{"name":"Focus Technologies, Herndon, Virginia 20171"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Sahm","sequence":"additional","affiliation":[{"name":"Focus Technologies, Herndon, Virginia 20171"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(95)00018-6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/598640"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1268"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/320186"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/26.2.247"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00158-8"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02185845"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.11.1964"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1300\/J100v05n03_05"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.882"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.557"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(95)00019-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(00)00234-0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/54.12.1420"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.3.382"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(94)90121-X"},{"key":"e_1_3_2_19_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing; eleventh informational supplement volume 22 no. 1. M100-S12. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/520195"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.1.156"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.7.3339-3343.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.7.3339-3343.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:38:20Z","timestamp":1646447900000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.41.7.3339-3343.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1128\/JCM.41.7.3339-3343.2003"],"URL":"https:\/\/doi.org\/10.1128\/jcm.41.7.3339-3343.2003","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"2003-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-04-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}